Plakous Therapeutics is a human biologics company that specializes in restorative and regenerative healing.
Plakous Therapeutics has raised $10K in total funding. The most recent round was Grant. The last funding was announced in December 2022.
Plakous Therapeutics's investors include Altis Biosystems, North Carolina Biotechnology Center, One North Carolina Small Business Program, The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Plakous Therapeutics is headquartered in Winston Salem, United States.
Plakous Therapeutics is a human biologics company that specializes in restorative and regenerative healing.
Plakous Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Plakous Therapeutics — Funding & Investors." VCBacked, December 20, 2022, https://www.vcbacked.co/company/plakous-therapeutics. Accessed September 30, 2026.
VCBacked. (2022). Plakous Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/plakous-therapeutics
{{cite web |title=Plakous Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/plakous-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated